Catalyst Pharmaceuticals Stock Analysis - Day Typical Price

CPRX Stock  USD 28.74  0.61  2.17%   
Typical Price is the average of the high, low, and close, providing a balanced view of intraday price action.

Day Typical Price Analysis Today

Typical Price is the average of the high, low, and close, providing a balanced view of intraday price action. The current Day Typical Price for Catalyst Pharmaceuticals is 28.57. This reading indicates consistent price behavior relative to the prior session.
VolatilityBacktestInformation Ratio  

Catalyst Pharmaceuticals Trading Date Momentum

On May 02 2026 Catalyst Pharmaceuticals was traded for 28.74 at the closing time. The top price for the day was 28.82 and the lowest listed price was 28.14 . Trading activity remained within a narrow range during the period. Price movement on May 2, 2026 remained within defined bounds. The net trading delta against the current closing price is -2.09% .
By including the close alongside the high-low range, Typical Price gives more weight to the settlement level than Median Price does. It is frequently used as an input for volume-weighted indicators and pivot point calculations.
Compare Catalyst Pharmaceuticals to competition

Related Price-Series Methods for Catalyst Pharmaceuticals

These methods summarize the same price history through smoothing, range, and momentum calculations. Reviewing them alongside Day Typical Price helps compare stable sessions with periods of wider price movement in Catalyst Pharmaceuticals.

Catalyst Pharmaceuticals Related Equities

The peer firms below within the Health Care space frame Catalyst Pharmaceuticals' pricing and running costs in context. Looking at Catalyst Pharmaceuticals' pricing multiples next to these peers shows if the stock trades at a premium or discount. How Catalyst Pharmaceuticals ranks within this group can shift over time as the competitive picture changes. This type of review is most informative when done often to track how positions shift over time.
 Risk & Return  Correlation

Catalyst Pharmaceuticals Market Strength Events

Rate of Change and Momentum readings for Catalyst Pharmaceuticals measure the velocity of recent price moves rather than direction alone. These indicators add context to how recent sessions in Catalyst Pharmaceuticals have behaved. These indicators are most informative when viewed alongside Catalyst Pharmaceuticals's volume profile and volatility measures. The Price Action Indicator distills each session's open-high-low-close into a single directional score for Catalyst Pharmaceuticals.

Catalyst Pharmaceuticals Risk Indicators

Standard deviation and variance for Catalyst Pharmaceuticals measure total price dispersion, while semi-deviation isolates only the downside moves. Higher variance relative to sector peers signals that Catalyst Pharmaceuticals' price path has been less predictable over the measured period. Analyzing Catalyst Pharmaceuticals' risk indicators helps explain how recent moves compare with its broader trading range. A narrow gap between mean deviation and standard deviation indicates that Catalyst Pharmaceuticals' return distribution is relatively symmetric.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Catalyst Pharmaceuticals Short Properties

Reviewing short-oriented indicators for Catalyst Pharmaceuticals is useful because long and short participants often create very different signals for timing and volatility. A disciplined short-interest review can make timing decisions more informed under rising skepticism.
Common Stock Shares Outstanding127.3 M
Cash And Short Term Investments709.2 M